IART

Integra Lifesciences Holdings

Stock NASDAQ – Stock Market Prices, News & Analysis

Integra Lifesciences focuses on the design, manufacture, and marketing of medical solutions in the field of neurosurgery and tissue repair.

$ 9.55
0.21 %

Integra Lifesciences Holdings

$ 9.55
0.21 %
IART

Integra Lifesciences focuses on the design, manufacture, and marketing of medical solutions in the field of neurosurgery and tissue repair.

Price history of Integra Lifesciences Holdings
Price history of Integra Lifesciences Holdings

Performance & Momentum

6 Months 38.27 %
1 Year 60.13 %
3 Years 81.85 %
5 Years 85.98 %
Momentum
79

Strategic Analysis

Integra Lifesciences Holdings • 2026

Integra Lifesciences positions itself as a specialized player in medical devices for neurosurgery and tissue repair, leveraging targeted technical expertise. Its business model relies on product innovation to meet the specific needs of complex surgical procedures.

Strengths
  • Specialization in a niche segment with high technological barriers
  • Strong presence in the American market, one of the largest in the medical industry
  • Product portfolio focused on high-technology interventions fostering customer loyalty
Weaknesses
  • Disappointing stock performance over several years, reflecting commercial or operational difficulties
  • Weak momentum indicating persistent negative pressure on the stock
Momentum

Current momentum is weak despite recent stabilization, suggesting a consolidation phase after a prolonged period of tension. Without strong external catalysts, valuation remains under pressure, which necessitates caution for investors seeking sustainable turnaround.

Analysis performed 1 week ago

Similar stocks to Integra Lifesciences Holdings

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone